-
1
-
-
0141504266
-
Iron deficiency and erythropoiesis: New diagnostic approaches
-
Brugnara C,. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003; 49: 1573-1578.
-
(2003)
Clin Chem
, vol.49
, pp. 1573-1578
-
-
Brugnara, C.1
-
3
-
-
41949113085
-
Iron deficiency anemia
-
Clark SF,. Iron deficiency anemia. Nutr Clin Pract 2008; 23: 128-141.
-
(2008)
Nutr Clin Pract
, vol.23
, pp. 128-141
-
-
Clark, S.F.1
-
4
-
-
79955958017
-
Hepcidin and iron regulation, 10 years later
-
Ganz T,. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-4433.
-
(2011)
Blood
, vol.117
, pp. 4425-4433
-
-
Ganz, T.1
-
5
-
-
77951619720
-
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
-
Lu M, Cohen MH, Rieves D, Pazdur R,. FDA report: ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol 2010; 85: 315-319.
-
(2010)
Am J Hematol
, vol.85
, pp. 315-319
-
-
Lu, M.1
Cohen, M.H.2
Rieves, D.3
Pazdur, R.4
-
6
-
-
65949107825
-
Ferric carboxymaltose: A review of its use in iron-deficiency anaemia
-
Lyseng-Williamson KA, Keating GM,. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009; 69: 739-756.
-
(2009)
Drugs
, vol.69
, pp. 739-756
-
-
Lyseng-Williamson, K.A.1
Keating, G.M.2
-
7
-
-
40649100958
-
Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia
-
Breymann C, Gliga F, Bejenariu C, Strizhova N,. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet 2008; 101: 67-73.
-
(2008)
Int J Gynaecol Obstet
, vol.101
, pp. 67-73
-
-
Breymann, C.1
Gliga, F.2
Bejenariu, C.3
Strizhova, N.4
-
8
-
-
52949101033
-
Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: A randomized controlled clinical trial
-
Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R,. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 2008; 199: 435.e1-4357.
-
(2008)
Am J Obstet Gynecol
, vol.199
-
-
Seid, M.H.1
Derman, R.J.2
Baker, J.B.3
Banach, W.4
Goldberg, C.5
Rogers, R.6
-
9
-
-
34548462994
-
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: A randomized controlled trial
-
(Pt 1):; Erratum in: Obstet Gynecol 2008;111:996
-
Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A,. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007; 110 (2 Pt 1): 267-278; Erratum in: Obstet Gynecol 2008;111:996.
-
(2007)
Obstet Gynecol
, vol.110
, Issue.2
, pp. 267-278
-
-
Van Wyck, D.B.1
Martens, M.G.2
Seid, M.H.3
Baker, J.B.4
Mangione, A.5
-
10
-
-
71849101678
-
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: A randomized, controlled trial
-
Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT,. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009; 49: 2719-2728.
-
(2009)
Transfusion
, vol.49
, pp. 2719-2728
-
-
Van Wyck, D.B.1
Mangione, A.2
Morrison, J.3
Hadley, P.E.4
Jehle, J.A.5
Goodnough, L.T.6
-
11
-
-
72449156527
-
Ferric carboxymaltose in patients with heart failure and iron deficiency
-
FAIR-HF Trial Investigators
-
Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P,; FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448.
-
(2009)
N Engl J Med
, vol.361
, pp. 2436-2448
-
-
Anker, S.D.1
Comin Colet, J.2
Filippatos, G.3
Willenheimer, R.4
Dickstein, K.5
Drexler, H.6
Lüscher, T.F.7
Bart, B.8
Banasiak, W.9
Niegowska, J.10
Kirwan, B.A.11
Mori, C.12
Von Eisenhart Rothe, B.13
Pocock, S.J.14
Poole-Wilson, P.A.15
Ponikowski, P.16
-
12
-
-
80052108611
-
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease
-
FERGI Study Group
-
Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C,; FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011; 141: 846-53.e1-2.
-
(2011)
Gastroenterology
, vol.141
-
-
Evstatiev, R.1
Marteau, P.2
Iqbal, T.3
Khalif, I.L.4
Stein, J.5
Bokemeyer, B.6
Chopey, I.V.7
Gutzwiller, F.S.8
Riopel, L.9
Gasche, C.10
-
13
-
-
79955586213
-
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis- dependent chronic kidney disease patients
-
Qunibi WY, Martinez C, Smith M, Benjamin J, Mangione A, Roger SD,. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. Nephrol Dial Transplant 2011; 26: 1599-1607.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 1599-1607
-
-
Qunibi, W.Y.1
Martinez, C.2
Smith, M.3
Benjamin, J.4
Mangione, A.5
Roger, S.D.6
-
14
-
-
0032510639
-
Prediction of coronary heart disease using risk factor categories
-
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB,. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
-
(1998)
Circulation
, vol.97
, pp. 1837-1847
-
-
Wilson, P.W.1
D'Agostino, R.B.2
Levy, D.3
Belanger, A.M.4
Silbershatz, H.5
Kannel, W.B.6
-
15
-
-
84881241741
-
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
-
2013 Mar 16. doi: 10.1002/jbmr.1923 [Epub ahead of print]
-
Wolf M, Koch TA, Bregman DB,. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 2013 Mar 16. doi: 10.1002/jbmr.1923 [Epub ahead of print].
-
J Bone Miner Res
-
-
Wolf, M.1
Koch, T.A.2
Bregman, D.B.3
-
16
-
-
84872951347
-
Hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anemia
-
Bregman DB, Morris D, Koch TA, He A, Goodnough LT,. Hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol 2013; 88: 97-101.
-
(2013)
Am J Hematol
, vol.88
, pp. 97-101
-
-
Bregman, D.B.1
Morris, D.2
Koch, T.A.3
He, A.4
Goodnough, L.T.5
|